No Detail Found!

Efficacy and Safety of Ketamine for the Management of Refractory Status Epilepticus (RSE) in Adults.

Author(s)
Jahanzeb Liaqat Military Hospital/National University of Medical Science (NUMS) Rawalpindi, Pakistan
Waseem Raja Military Hospital/National University of Medical Science (NUMS) Rawalpindi, Pakistan
Waseem Wali Military Hospital/National University of Medical Science (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the efficacy and safety of ketamine (KE) in the management of refractory status epilepticus (RSE) in adults. Study Design: Open Label, unblinded prospective case series. Place and Duration of Study: The study was conducted at Neurology Department Military Hospital Rawalpindi, from Jan 2014 to Dec 2014. Material and Methods: All the patients with status epilepticus, from Jan 2014 to Dec 2014 were treated with ketamine in addition to benzodiazepines, phenytoin and levitricetam. Ketamine was the last drug added and if seizures were still not controlled then anesthetic agents like thiopental and propofol were used. Results: Between Jan 2014 and Dec 2014, twenty patients received IV Ketamine. In 18 patients RSE lasted for more than 24 hours, with a median of 4 days (range 1-8 days). Mean duration of seizures in the study group was 4.45 days (SD 2.01). Ketamine was successful in terminating seizure activity in 40% (n=8) patients while it failed in 15% (n=3) patients. There was additional 15% (n=3) partial response in the form of initial control but these patients had later breakthrough or with drawl seizures. Twenty five percent (n=5) of the patients died during the treatment while in one patient ketamine had to be stopped because of intolerable side effects. In our patients the adverse effects of ketamine included sepsis (35%, 5, n=7), shock (10%, n=2) and pneumonia (10%, n=2). Conclusion: In this small, open-label, unblinded study KE appears effective and safe in treating RSE in adults. Larger, randomized studies will help to confirm data emerging from this preliminary study.
Publication Details
Page(s) 64-68
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 1, Year: 2018

Request the full text from PASTIC

References
2015.cited 2015 1st February],Wikipedia -
LowensteinDH,AlldredgeBK, 1998.Status epilepticus,N Engl J Med 338 970 -6
BrophyGM,BellR,ClaassenJ,AlldredgeB,BleckTP,GlauserT, 2012.Guidelines for the evaluation and management of status epilepticus,Neurocritical care 17 3 -23
DeLorenzoRJ,PellockJM,TowneAR,BoggsJG, 1995.Epidemiology of status epilepticus,J Clin Neurophysiol 12 316 -25
MacdonaldRL,KellyKM, 1994.Mechanisms of action of currently prescribed and newly developed antiepileptic drugs,Epilepsia 35 S41 -50
GoodkinHP,KapurJ., 2009.The impact of diazepam's discovery on the treatment and understanding of status epilepticus,Epilepsia 50 2011 -8
MazaratiAM,WasterlainCG, 1999.N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat,Neurosci Lett 265 187 -90
BorrisDJ,BertramEH,KapurJ, 2000.Ketamine controls prolonged status epilepticus,Send to Epilepsy Res 42 117 -22
GaspardN,ForemanB,JuddLM,BrentonJN,NathanBR,McCoyBM, 2013.Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multi-center study,Epilepsia 54 1498 -503
ZeilerFA,TeitelbaumJ,GillmanLM,WestM., 2014.NMDA antagonists for refractory seizures,Neurocrit Care 20 502 -13
FerlisiM,ShorvonS., 2012.The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy,Brain 135 2314 -28
SynowiecAS,SinghDS,YenugadhatiV,ValerianoJP,SchramkeCJ,KellyKM, 2013.Ketamine use in the treatment of refractory status epilepticus,Epilepsy Res 105 183 -8
RosatiA,L'ErarioM,IlventoL,CecchiC,PisanoT,MirabileL, 2012.Efficacy and safety of ketamine in refractory status epilepticus in children,Neurology 79 2355 -8
ClaassenJ,HirschLJ,EmersonRG,MayerSA, 2002.Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review,Epilepsia 43 146 -53
ZeilerFA, 2015.Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus,Critical care research and practice 831260 -
NovyJ,LogroscinoG,RossettiAO, 2010.Refractory status epilepticus: a prospective observational study,Epilepsia 51 251 -6
0

Citations

0

Downloads

101

Views